Emmanuel Scotet INSERM, CNRS, Université d'Angers, Université de Nantes CRCINA Biography Publications Institution JoVE Articles Emmanuel Scotet has not added a biography. If you are Emmanuel Scotet and would like to personalize this page please email our Author Liaison for assistance. Publications Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells Frontiers in Immunology. 2018 | Pubmed ID: 29731756 IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors Journal of Immunotherapy (Hagerstown, Md. : 1997). Jun, 2018 | Pubmed ID: 29683891 Impact on Early Outcomes and Immune Reconstitution of High-dose Post-transplant Cyclophosphamide Vs Anti-thymocyte Globulin After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Transplantation Oncotarget. Feb, 2018 | Pubmed ID: 29545911 Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2017 | Pubmed ID: 28720668 The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells Journal of Immunology (Baltimore, Md. : 1950). 06, 2017 | Pubmed ID: 28461569 Butyrophilin 3A (BTN3A, CD277)-specific Antibody 20.1 Differentially Activates Vγ9Vδ2 TCR Clonotypes and Interferes with Phosphoantigen Activation European Journal of Immunology. 06, 2017 | Pubmed ID: 28386905 Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Inmunología e infección
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Inmunología e infección